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Spartan deﬁciency causes genomic instability
and progeroid phenotypes
Reeja S. Maskey1,*, Myoung Shin Kim2,*, Darren J. Baker3, Bennett Childs1, Liviu A. Malureanu1,
Karthik B. Jeganathan1, Yuka Machida2, Jan M. van Deursen1 & Yuichi J. Machida2,4
Spartan (also known as DVC1 and C1orf124) is a PCNA-interacting protein implicated in
translesion synthesis, a DNA damage tolerance process that allows the DNA replication
machinery to replicate past nucleotide lesions. However, the physiological relevance of
Spartan has not been established. Here we report that Spartan insufﬁciency in mice causes
chromosomal instability, cellular senescence and early onset of age-related phenotypes.
Whereas complete loss of Spartan causes early embryonic lethality, hypomorphic mice with
low amounts of Spartan are viable. These mice are growth retarded and develop cataracts,
lordokyphosis and cachexia at a young age. Cre-mediated depletion of Spartan from
conditional knockout mouse embryonic ﬁbroblasts results in impaired lesion bypass,
incomplete DNA replication, formation of micronuclei and chromatin bridges and eventually
cell death. These data demonstrate that Spartan plays a key role in maintaining structural
and numerical chromosome integrity and suggest a link between Spartan insufﬁciency
and progeria.
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U
ninterrupted DNA replication is important for timely
duplication of the genome before mitotic entry. However,
the replication machinery may stall or slow down on
replication stress caused by DNA lesions, limited nucleotide pools
and repetitive DNA sequences1. Failure to deal with such
replication stress could lead to genomic instability, which is
associated with cancer and ageing2,3. In fact, genetic defects in
replicative stress response have been implicated in genome
instability syndromes that are characterized by increased cancer
incidence and/or premature ageing phenotypes1. Although
replication stress has been commonly linked to cancer
susceptibility, accumulating evidence from mouse studies also
supports the role of replication stress in premature ageing
phenotypes and ageing of stem cells4–6.
Genomic DNA lesions are one of the common sources of
replication stress. Because high-ﬁdelity replicative polymerases
cannot accommodate damaged bases in their active sites,
unrepaired DNA lesions pose a risk of replication fork stalling,
double-strand DNA breaks and cell death. To avoid such threat to
genome stability, cells are equipped with a special replication
system called translesion synthesis (TLS), which allows contin-
uous replication across DNA lesions7,8. During TLS,
monoubiquitination of proliferating cell nuclear antigen
(PCNA), a sliding clamp for DNA polymerases, induces
switching from replicative DNA polymerases to specialized TLS
polymerases, thereby allowing bypass of DNA lesions. Although
TLS protects replication forks from stalling at DNA lesions, it is
potentially mutagenic because it utilizes error-prone DNA
polymerases.
Spartan was recently identiﬁed as a novel regulator of TLS that
guards against TLS-associated mutagenesis9–15. Spartan is
recruited to DNA damage sites through the interaction with
PCNA via its PIP (PCNA-interacting peptide) motif and the
interaction of the zinc-ﬁnger domain UBZ4 with ubiquitin on
PCNA or other proteins9–14. Several groups reported that Spartan
promotes monoubiquitination of PCNA9,10,14, thereby facilitating
recruitment of TLS polymerases, whereas other groups showed
that Spartan recruits an ATP-dependent segregase p97 (also
known as valosin-containing protein (VCP)) to the sites of TLS to
facilitate dissociation of TLS polymerases12,13. In addition, our
previous study linked Spartan to regulation of the error-prone
TLS mechanism involving the DNA polymerase Pol z15. While
these studies clearly implicated Spartan in TLS regulation,
whether Spartan is required for TLS is unknown.
In this study, we create Sprtn-targeted mouse models and
investigate the physiological importance of Spartan. We demon-
strate essential roles of Spartan in lesion bypass, completion of
DNA replication, genome stability and cell viability. Interestingly,
Sprtn insufﬁciency causes senescence and progeria in mice. Our
ﬁndings establish the critical role of Spartan in the cell cycle and
the maintenance of genome integrity and provide the link
between Spartan insufﬁciency and progeria.
Results
Sprtn knockout causes embryonic lethality in mice. To explore
the physiological relevance of Spartan, we generated a series of
mice with graded reduction in Spartan expression using hypo-
morphic (H) and knockout (KO) Sprtn alleles that we generated
by gene targeting (Fig. 1a,b). Intercrossing of Sprtnþ / mice
failed to produce Sprtn / -live offspring and no Sprtn /
embryos were found from embryonic day (E) 7.5 to E13.5
(Table 1), suggesting that Sprtn KO in mice causes early
embryonic lethality. To examine the effect of Sprtn KO on early
embryogenesis, we isolated blastocysts at E3.5 and cultured them
in vitro for 6 days. Genotyping was successful for all the
blastocysts collected, and Sprtn / blastocysts were obtained at
normal Mendelian frequency (Fig. 1c; Table 2). However,
Sprtn / blastocysts failed to hatch and enlarge the inner cell
mass when cultured in vitro (Fig. 1d; Table 2), indicating that
death occurred prior at the implantation stage.
Effects of Sprtn KO on cell proliferation and survival. To
further investigate the role of Sprtn at the cellular level, we
generated a conditional Sprtn KO system in mouse embryonic
ﬁbroblasts (MEFs). Sprtnþ /þ , SprtnF/þ and SprtnF/ MEFs
were immortalized and transduced with retroviruses expressing
Cre-ERT2. Treatment with 4-hydroxytamoxifen (4-OHT)
resulted in excision of exon 2, efﬁciently converting the
ﬂoxed allele to a KO allele (Fig. 2a). SprtnF/ MEFs, but not
Sprtnþ /þ and SprtnF/þ MEFs, showed markedly reduced
proliferation and increased apoptosis after exposure to 4-OHT
(Fig. 2b,c), suggesting that Sprtn is essential for cell proliferation
and survival.
Cell cycle effects from the loss of Sprtn. To determine whether
Sprtn KO has any effects on the cell cycle, we examined the cell
cycle proﬁle of MEFs with various genotypes by ﬂow cytometry.
A large portion of 4-OHT-treated SprtnF/ MEFs accumulated
with 4C DNA content after treatment, whereas Sprtnþ /þ and
SprtnF/þ cells were unaffected (Fig. 2d). To examine S-phase
progression of Sprtn / MEFs more closely, we performed
5-bromodeoxyuridine (BrdU) pulse-chase experiments, in which
S-phase cells were pulse labelled with BrdU and chased in BrdU-
free media every 2 h (Supplementary Fig. 1a). Sprtn / MEFs
initially progressed through S phase at a similar rate to wild-type
cells, but subsequently arrested with 4C DNA content at high rates
(Supplementary Fig. 1b). These results suggest that Sprtn / cells
exhibit normal S-phase progression, but accumulate in late S or
G2/M phases. A relatively small proportion of Sprtn / MEFs
were positive for p-H3Ser10, a well-established mitotic marker16,17,
indicating that Sprtn / cells accumulate before entry into
mitosis (Supplementary Fig. 1c). Collectively, these results suggest
that Spartan is essential for cell proliferation and faithful
progression through late S and G2 phases.
The Spartan protein possesses multiple domains including
SprT (a zinc metalloprotease-like domain), a SHP box (a p97-
interacting motif), a PIP box (a PCNA-interacting motif) and
UBZ4 (a ubiquitin-binding domain) (Fig. 2e, top). We asked
whether these domains are necessary for the function of Spartan
in the cell cycle. Wild-type human Spartan, which was expressed
at the similar level to endogenous Spartan in a human ﬁbroblast
cell line (Supplementary Fig. 2a), suppressed accumulation of
cells in late S or G2 phase following loss of Sprtn in MEFs
(Fig. 2e). On the other hand, SpartanE112A, a mutant with a
substitution in the putative active site of the metalloprotease-like
domain SprT15, failed to rescue the cell cycle defect in Sprtn /
MEFs despite the similar expression level to wild-type Spartan
(Fig. 2e; Supplementary Fig. 2a). In contrast, the ectopic
expression of human SpartanPIP* and SpartanUBZ*, which
exhibit diminished interactions with PCNA and ubiquitin,
respectively11, efﬁciently suppressed the cell cycle defect in
Sprtn / MEFs (Supplementary Fig. 2b,d). Similarly, mouse
SpartanSHP*, which harbours the mutations that diminish
interaction with p97 (ref. 13), also suppressed the cell cycle
defect in Sprtn / MEFs as efﬁciently as wild-type Spartan
(Supplementary Fig. 2c,e). Altogether, these results suggest that
the putative active site of the SprT domain is essential for the cell
cycle function of Spartan, while the PIP, UBZ and SHP domains
are dispensable.
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Loss of Spartan causes DNA damage and checkpoint activa-
tion. To determine the cause of the cell cycle defect in
Sprtn / MEFs, we asked whether Spartan deﬁciency
engages the DNA damage response pathway. gH2AX foci,
a marker of DNA damage18, markedly increased in SprtnF/
MEFs after 4-OHT treatments, but not in Sprtnþ /þ and
SprtnF/þ MEFs (Fig. 3a). Consistent with increased DNA
damage, Sprtn / MEFs showed high rates of double-
strand DNA breaks as measured by immunostaining of
the DNA recombination protein Rad51 (Fig. 3b) and
profound activation of the checkpoint kinase Chk2 (Fig. 3c).
Thus, loss of Sprtn in MEFs seemingly induces DNA damage,
most likely DNA breaks, leading to activation of the DNA
damage checkpoint.
Depletion of Spartan causes genomic instability. The elevated
levels of DNA damage accompanied by checkpoint activation in
Sprtn / MEFs prompted us to assess whether loss of
Spartan induces genomic instability. Microscopic analysis of 40,6-
diamidino-2-phenylindole (DAPI)-stained MEFs revealed that
a substantial fraction of mitotic Sprtn / MEFs exhibited
chromatin bridges and micronuclei, structures that have been
associated with unresolved replication intermediates and unre-
paired DNA breaks19 (Fig. 4a–c). In addition, these MEFs had
increased numbers of 53BP1 nuclear bodies that signify
incomplete DNA replication20,21 (Fig. 4d). These data raise the
possibility that the genome of Sprtn-deﬁcient cells is subject to
under-replication. Consistent with this interpretation, the vast
majority of chromosomal abnormalities observed in the mitotic
spreads of Sprtn / MEFs were chromosome gaps, which might
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Figure 1 | Sprtn KO causes embryonic lethality. (a) Schematic of the mouse Sprtn gene and the targeted alleles. An inverted Neo cassette was inserted in
the second intron with ﬂanking FLP recognition target (FRT) sequences. LoxP sites were also inserted at the indicated positions. The ﬂoxed and KO alleles
were created by crossing heterozygote mice with FLP and Cre-transgenic mice, respectively. Positions of genotyping primers are indicated by arrows. (b)
PCR-based genotyping (at weaning) of wild-type and Sprtn heterozygote mice produced by intercrossing Sprtnþ / . (c) PCR-based genotyping of wild-
type, heterozygote and KO blastocysts. (d) Blastocysts from Sprtnþ / intercrosses were cultured in vitro and observed by phase-contrast microscopy on 6
consecutive days. Representative images of Sprtnþ /þ , Sprtnþ / and Sprtn / blastocysts are shown. Scale bar, 100 mm.
Table 1 | Genotypes of offspring and embryos from
Sprtnþ / intercrosses.
Developmental
stages
Sprtnþ /þ Sprtnþ / Sprtn / Total
E3.5 6 (24.0%) 13 (52.0%) 6 (24.0%) 25
E7.5 5 (25.0%) 15 (75.0%) 0 20
E9.5 5 (26.3%) 14 (73.7%) 0 19
E11.5 7 (31.8%) 15 (68.2%) 0 22
E13.5 6 (30.0%) 14 (70.0%) 0 20
P21 85 (41.5%) 120 (58.5%) 0 205
E, embryonic day; P, postnatal day.
Table 2 | In vitro development of blastocysts.
Genotype Number of
blastocysts
Number of blastocysts presenting
Zona hatching
at day 3
ICM outgrowth
at day 6
Sprtnþ /þ 6 6 6
Sprtnþ / 13 12 12
Sprtn / 6 0 0
ICM, inner cell mass.
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represent under-replicated regions (Fig. 4e,f). In summary, these
results suggest that Spartan is crucial for maintaining genome
integrity.
Lesion bypass defects in Sprtn / cells. To examine the effect
of Sprtn inactivation on DNA replication more directly, we
measured movement of replication forks in Sprtn / MEFs
using DNA ﬁber assays, in which replication tracts were
sequentially labelled with the thymidine analogues IdU and CldU
(Fig. 5a). Lengths of CldU-labelled DNA in Sprtn / MEFs were
not signiﬁcantly different from those of Sprtnþ /þ MEFs
(Fig. 5b), suggesting that the majority of replication forks are not
affected by Spartan loss, an observation consistent with the
normal S-phase progression in Sprtn / cells (Supplementary
Fig. 1b).
Given that Sprtn / cells have mostly intact replication forks
but still accumulate in late S/G2 phases accompanied by under-
replication phenotypes, we hypothesized that Spartan might be
important for DNA replication under stress, for example,
imposed by endogenously created DNA lesions. Previous reports
have indeed linked Spartan’s function to TLS9–15, although
whether Spartan is necessary for the bypass of DNA lesions
during DNA replication has not been established. We therefore
tested the requirement of Spartan for lesion bypass during DNA
replication. DNA ﬁber assays were performed with ultraviolet
light exposure, which introduces lesions acted on by TLS, between
IdU and CldU labelling (Fig. 5a). Lesion bypass efﬁciency is
expressed as elongation ratios (CldU/IdU), which would be
reduced with lesion bypass defects. Strikingly, Sprtn KO in MEFs
caused reduced fork progression at ultraviolet-induced lesions
(Fig. 5c), suggesting that Spartan is important for ultraviolet-
induced lesion bypass. We also examined whether Spartan plays a
role in the stability of stalled forks by measuring replication fork
restart after hydroxyurea (HU) treatments (Supplementary
Fig. 3a). Sprtn KO did not increase the amount of collapsed
forks on HU treatments (Supplementary Fig. 3b), suggesting that
Spartan is not necessary for replication restart after fork stalling.
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Figure 2 | Sprtn KO causes impaired cell proliferation and cell death. (a) PCR-based genotyping of Sprtn alleles in the indicated MEF lines after 48 h
treatment with MeOH or 2mM 4-OHT. (b) Proliferation of Sprtn-targeted MEFs. Cells treated with MeOH or 4-OHT for 48 h were seeded and cell
numbers were counted at the indicated time points. Values are mean±s.d. of three independent experiments. (c) Analyses of apoptosis in Sprtn-targeted
MEFs. Two days after the completion of 48 h treatment with MeOH or 4-OHT, cells were stained with Annexin V and PI and analysed by ﬂow cytometry.
Values are mean±s.d. of three independent experiments. NS, not signiﬁcant; ***Po0.001 (two-tailed unpaired t-test). (d) Cell cycle proﬁling of
Sprtn-targeted MEFs. The indicated MEF lines were treated with MeOH or 4-OHT for 48 h. Two days later, cells were stained with PI and analysed by ﬂow
cytometry. (e) Cell cycle proﬁling of SprtnF/F; Cre-ERT2 MEFs (K3) expressing wild-type human Spartan or the E112A mutant after 48 h treatment with
MeOH or 4-OHT.
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Next we assessed the requirement of the Spartan domains for
the bypass of ultraviolet-induced lesions by re-expressing Spartan
mutants in conditional Sprtn KO MEFs. The lesion bypass defect
in Sprtn / cells was rescued by the introduction of wild-type
human Spartan, but not the mutant that harbours the E112A
mutation in the putative active site (Fig. 5d), suggesting that the
role of Spartan in lesion bypass requires an intact SprT domain.
On the other hand, the PIP*, UBZ4* or SHP* mutants of Spartan
exhibited partially diminished abilities to rescue the lesion bypass
defects in Sprtn / MEFs (Fig. 5e,f). Taken together, these
results suggest that Spartan is dispensable for the replication of
the bulk of the genome, but is crucial for replication past DNA
damage. This function of Spartan in lesion bypass depends on the
putative active site of the SprT domain, but only partially on the
PIP, UBZ4 and SHP domains.
To obtain more insight into the role of Spartan in lesion
bypass, we examined the effect of Sprtn KO on PCNA
ubiquitination in response to ultraviolet irradiation and dissocia-
tion of Pol Z from ultraviolet-induced DNA damage sites, the two
processes that have been reported to be impaired in Spartan-
depleted human cells9,10,12–14. PCNA ubiquitination after
ultraviolet irradiation was largely intact in Sprtn / cells
(Supplementary Fig. 3c), suggesting that Spartan is not
absolutely necessary for ultraviolet-induced PCNA
ubiquitination. On the other hand, in agreement with previous
reports12,13, we observed prolonged retention of enhanced green
ﬂuorescent protein (EGFP)-Pol Z foci after ultraviolet irradiation
in Sprtn / cells (Supplementary Fig. 3d), although it remains
to be determined whether this is due to a failure to extract Pol Z
from DNA damage sites as proposed previously12,13 or it reﬂects
the lesion bypass defects we report in this study (Fig. 5c).
Growth defects and genome instability in SprtnH/ cells.
Finally, we examined the effect of Sprtn insufﬁciency by produ-
cing Sprtn hypomorphic mice. The targeted SprtnNeo allele is
hypomorphic (hereafter referred to as SprtnH), producing wild-
type mRNAs at reduced levels due to the cryptic exon in the Neo
cassette22 (Supplementary Fig. 4a). In contrast to Sprtn /
MEFs, SprtnH/ MEFs, which contain one KO and one
hypomorphic allele that produce reduced amounts of wild-type
Spartan, were viable, but proliferated at reduced rates
(Supplementary Fig. 4b–d). Furthermore, SprtnH/ MEFs had
increased rates of aneuploidy and micronuclei (Supplementary
Fig. 4e,f; Supplementary Table 1), indicating that, in addition to
structural chromosome damage, Spartan insufﬁciency leads to
numerical chromosome instability.
Growth defects and genomic instability in SprtnH/H mice.
Although no viable SprtnH/ offspring were found in crossing of
Sprtnþ / and Sprtnþ /H mice, SprtnH/H mice were born at near
Mendelian frequency from Sprtnþ /H breeding pairs (Sprtnþ /þ ,
Sprtnþ /H and SprtnH/H at 26.6, 53.3 and 20.1%, respectively),
despite substantially reduced Sprtn expression (Fig. 6a,b). At
weaning, SprtnH/H mice appeared healthy but were overtly
smaller than control littermates. Dwarﬁsm was observed in both
sexes and persisted as SprtnH/H mice developed to adulthood
(Fig. 6c). To investigate in more detail the effects of Sprtn
insufﬁciency in SprtnH/H mice, we isolated primary lung ﬁbro-
blasts and prostate epithelial cells from Sprtnþ /þ and SprtnH/H
mice. Sprtn expression was reduced to less than 10% in the
SprtnH/H cells (Supplementary Fig. 5a,b). SprtnH/H lung ﬁbro-
blasts showed elevated structural and numerical chromosomal
instabilities, as evidenced by increased rates of gH2AX foci,
aneuploidy and micronuclei (Fig. 6d,e; Table 3). In addition,
SprtnH/H lung ﬁbroblasts displayed defects in fork progression at
ultraviolet-induced lesion, which was also conﬁrmed in SprtnH/H
prostate epithelial cells (Fig. 6f; Supplementary Fig. 5c). Taken
together, these results indicate that cells from Sprtn hypomorphic
mice exhibit genome instability and lesion bypass defects.
Reduced expression of Sprtn causes accelerated ageing in mice.
As young adults, SprtnH/H mice exhibited no overt phenotypes
other than dwarﬁsm. However, by 12 months of age, all SprtnH/H
mice (seven out of seven mice) had developed lordokyphosis
(concavity in the curvature of the lumbar and cervical spine),
cataracts and cachexia (Fig. 7a,b), three phenotypes often seen in
mouse models of progeria23–25. The total fat mass and percentage
of body fat of these mice were dramatically reduced (Fig. 7c). In-
depth analysis of individual fat depots revealed that the relative
weights of the paraovarian, inguinal adipose tissue (IAT),
perirenal and subscapular adipose tissue were all signiﬁcantly
reduced in size (Fig. 7c). Consistent with fat tissue atrophy, fat
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Figure 3 | Sprtn KO causes DNA damage and checkpoint activation.
(a) gH2AX focus formation. The indicated MEFs treated with MeOH or
4-OHT for 48 h were stained with anti-gH2AX. At least 300 cells were
scored for gH2AX foci and percentages of cells with 5 or more foci are
shown. Values are mean±s.d. of three independent experiments. NS, not
signiﬁcant; *Po0.05; ****Po0.0001 (two-tailed unpaired t-test). (b) Rad51
focus formation. The indicated MEFs were stained with anti-Rad51 after
48 h treatment with MeOH or 4-OHT. At least 300 cells were scored for
Rad51 foci. Experiments were performed in triplicate and mean±s.d. is
shown. ****Po0.0001 (two-tailed unpaired t-test). (c) Western blot
analyses of phospho-Chk1 and Chk2. The indicated MEFs were treated with
4-OHT and harvested at various time points. SprtnF/ (H7) cells treated
with ultraviolet (40 Jm 2) or ionizing radiation (10Gy) are shown as
positive controls for checkpoint kinases activation. Chk1 is used as a loading
control. P-Chk1, phospho-Chk1 (Ser345); P-Chk2, phospho-Chk2.
Uncropped blots are shown in Supplementary Fig. 7.
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cells in SprtnH/H IAT were signiﬁcantly smaller in size (Fig. 7d).
Furthermore, IAT stained highly positive for senescence-
associated-b-galactosidase (SA-b-GAL) and showed increased
levels of key senescence markers, including p16Ink4a, p19Arf and
PAI-1 (Fig. 7e,f). These data suggest that increased accumulation
of cellular senescence in fat causes dysfunction and atrophy of
this tissue. Lordokyphosis in progeroid mouse models is often
associated with osteoporosis and/or muscle wasting24,26.
However, neither disorder seemed to apply to SprtnH/H mice as
their bone mineral content and density (Supplementary Fig. 6a,b)
and gastrocnemius, abdominal and paraspinal muscle ﬁbre
diameters (Supplementary Fig. 6c–e) were normal. Consistent
with segmental progeria, SprtnH/H mice showed impaired exercise
ability as measured by the use of a treadmill: the duration of
exercise, the distance travelled and the overall amount of work
performed were all reduced at the age of 12 months (Fig. 7g).
Taken together, these data suggest that the reduced expression of
Sprtn leads to development of various progeroid phenotypes,
including dwarﬁsm, cataracts, lordokyphosis, fat tissue
dysfunction and accumulation of senescent cells.
Discussion
In this study, we investigate the physiological roles of Spartan
using a series of mice with graded reduction in Sprtn expression.
Our data uncover a striking requirement of Spartan in cell
survival and mouse development. Speciﬁcally, Sprtn KO causes
early embryonic lethality in mice, while conditional KO in MEFs
leads to incomplete DNA replication and cell death. In contrast,
Sprtn hypomorphic mice are viable but develop premature ageing
phenotypes accompanied by elevated levels of DNA damage and
genome instability. Extending previous studies that implicated
Spartan in TLS, we demonstrate that lesion bypass is impaired in
Sprtn KO and hypomorphic cells when assayed with external
DNA damage. Taken together, our data best ﬁt a model whereby
Spartan is essential for DNA replication under stress, which can
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Figure 4 | Genome instability in Sprtn KO MEFs. (a) Images showing chromatin bridges (arrows) and micronuclei (arrowheads) in SprtnF/ MEFs treated
with MeOH or 4-OHT for 48 h. DNA was visualized by DAPI staining. (b) Quantitation of chromatin bridges. Experiments were performed as in a. At
least 300 cells were scored for chromatin bridges and percentages of positive cells are shown. Three independent experiments were performed and
mean±s.d. is shown. ****Po0.0001 (two-tailed unpaired t-test). (c) Quantitation of micronuclei-containing cells. Experiments were performed as in a.
****Po0.0001 (two-tailed unpaired t-test). (d) Formation of 53BP1 nuclear bodies. SprtnF/ MEFs were treated with MeOH or 4-OHT for 48h. At
least 300 cells were scored for 53BP1 nuclear bodies and percentages of nuclei with different number of 53BP1 nuclear bodies per nucleus are shown.
(e) Chromosomal abnormalities in Sprtn KO cells. SprtnF/ MEFs were treated with MeOH or 4-OHT for 48 h. Twelve hours after completion of the
treatments, mitotic spreads were prepared and examined by microscopy. Representative pictures of mitotic spreads are shown in the left panel. Arrows
indicate some of the chromosome abnormalities. In the right panel, representative images of chromosome gaps in Sprtn KO MEFs are indicated by
arrowheads. (f) Quantitation of abnormal chromosomes. Cells harbouring chromosomal abnormalities were scored in 50 mitotic spreads of SprtnF/ MEFs
treated with MeOH or 4-OHT.
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be imposed by DNA lesions or difﬁcult-to-replicate sequences
such as repetitive DNA elements. This model is also consistent
with previous studies that have linked replication stress with age-
related phenotypes in mice4–6. In summary, our ﬁndings reveal
the fundamental role of Spartan in the cell cycle and genome
stability and support the link between deﬁciency in replication
stress response and progeria.
To our knowledge, the current study is the ﬁrst to demonstrate
the requirement of Spartan in lesion bypass. This suggests that
Spartan plays a more fundamental function than just suppressing
damage-induced mutations. Our experiments using a various
Spartan mutants provide mechanistic insight into the role of
Spartan in lesion bypass. The results indicate that bypass
of ultraviolet-induced lesions is dependent on the SprT domain
of Spartan but only partially on the SHP, PIP and UBZ4 domains
(Fig. 5d–f). The dependence on the SprT domain is consistent
with our previous observation that suppression of ultraviolet-
induced mutagenesis by Spartan required an intact SprT
domain15. On the other hand, the partial requirement of the
PIP and UBZ4 domains indicates that recruitment of Spartan to
ubiquitinated PCNA is important, but not absolutely necessary
for Spartan’s function in lesion bypass. This is consistent with the
report that PCNA ubiquitination is important but not absolutely
required for TLS27. Although not absolutely required, the SHP
box of Spartan clearly has an important role in lesion bypass.
Previous reports suggested a model in which the Spartan-p97
interaction facilitates p97-mediated removal or degradation of
Pol Z from DNA damage sites. Consistent with this model,
Sprtn / MEFs showed prolonged retention of ultraviolet-induced
Pol Z foci (Supplementary Fig. 3d). Our ﬁndings that both the SprT
domain and the SHP box are involved in lesion bypass raise an
intriguing possibility that p97 and the SprT domain of Spartan
cooperate in polymerase switching at the sites of TLS.
Although it is not clear why Sprtn KO cells die, it is tempting to
speculate that failure to execute TLS is a major contributing factor
given that the catalytic subunit of the TLS polymerase Pol z has
been shown to be essential in mice28–33. Consistently, our previous
study implicated Spartan in regulation of Pol z15. Therefore,
Spartan might be required for efﬁcient TLS in response to stalled
replication at endogenous DNA damage sites, thereby allowing
cells to complete S phase. In addition, given that TLS polymerases
are important for efﬁcient replication and stability of difﬁcult-to-
replicate sequences34–37, it is possible that Spartan-deﬁcient cells
exhibit cell cycle defects and genome instability due to replication
failure at the sites of inherent replication stress such as difﬁcult-to-
replicate regions. Alternatively, given the previous observation that
Spartan interacts with the DNA polymerase d subunit10,15, it is
possible that Spartan has a more general role in DNA replication
unrelated to the TLS pathway. In this case, Spartan might be
dispensable for replication of the majority of the genome, with only
certain regions requiring Spartan function. Our experiments found
that distinguishing these two possibilities might be challenging,
because PIP and UBZ4, two TLS-linked domains of Spartan, were
not only dispensable for cell viability (Supplementary Fig. 2d), but
also not completely required for the function of Spartan in lesion
bypass (Fig. 5e). In contrast, we found that the SprT is necessary
for both lesion bypass and cell viability (Fig. 5d). Therefore,
functional studies of the putative zinc metalloprotease domain in
TLS or other processes will clarify the cause of incomplete DNA
replication and cell death following Sprtn KO.
We ﬁnd that Spartan deﬁciency leads to both structural and
numerical chromosome instabilities, both of which have been
associated with cancer predisposition. SprtnH/H mice sacriﬁced at
1 year of age were thoroughly screened for the presence of
tumours, but none were detected. On the other hand, with 100%
penetrance, these mice presented multiple age-related and
progeroid phenotypes, suggesting that the genomic stress
resulting from Spartan insufﬁciency predominantly engages
signalling pathways that have been associated with cell fate
decisions that negatively impact tissue homeostasis and repair,
such as the p53 and the p16Ink4a tumour suppressor pathways38.
Consistent with this, we observed a profound accumulation of
senescent cells in fat tissue of Spartan-insufﬁcient mice, as well as
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Figure 5 | Effects of Sprtn KO on DNA replication forks. (a) Schematic
representation of DNA ﬁber assays. MEFs were treated with MeOH or
4-OHT for 48 h and sequentially labelled with IdU and CldU to mark
ongoing replication. A picture of a representative replication track is shown.
At least 100 ﬁbres were scored for each sample in all of the DNA ﬁber
experiments. (b) A box plot showing distribution of the lengths of CldU
tracts in SprtnF/ MEFs treated with MeOH or 4-OHT for 48 h. NS, not
signiﬁcant (P¼0.829, two-tailed unpaired t-test). (c) Effect of ultraviolet
irradiation on replication forks. DNA ﬁber assays were performed with
SprtnF/ MEFs with or without ultraviolet irradiation (40 Jm 2) between
IdU and CldU labelling. Distribution of replication forks at different CldU/
IdU ratios is shown. (d–f) Effect of ultraviolet irradiation on replication
forks. Experiments were performed as in c using SprtnF/F; Cre-ERT2 MEFs
(K3) expressing wild-type human Spartan or the E112A mutant (d), wild-
type human Spartan, the PIP* or the UBZ* mutant (e), and wild-type mouse
Spartan or the SHP* mutant (f). Horizontal red lines in c–f indicate median
values.
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increased levels of p16Ink4a. Several genome maintenance
syndromes have exclusively been associated with progeria,
including Cockayne syndrome, trichothiodystrophy, Rothmund-
Thomson and dyskeratosis congenital, while others, including
Fanconi anaemia, xeroderma pigmentosum, ataxia telangiectasia,
Nijmegen breakage syndrome, Bloom syndrome and Werner
syndrome, cause both cancer and progeroid phenotypes39. Our
data suggest that Spartan insufﬁciency primarily causes progeria;
however, it will be important to screen a larger cohort of SprtnH/H
mice for tumour formation in future studies. While this
manuscript was under review, Lessel et al.40 reported biallelic
germline mutations in Sprtn in human patients with a new
segmental progeroid syndrome. Accelerated ageing in Sprtn
hypomorphic mice in our study is consistent with the progeria in
the human patients, and our study provides a ﬁrm link between
Spartan insufﬁciency and premature ageing.
In conclusion, the current study provides the evidence that
Spartan is essential for the normal cell cycle and cell viability. Our
data strongly suggest that Spartan deﬁciency causes cell cycle
defects through accumulation of incompletely replicated genomic
regions. Further studies on the potential enzyme activity of the
SprT domain will reveal the full function of Spartan and provide
insight into the mechanism by which insufﬁciency of Spartan
leads to genome instability and progeria.
Methods
Generation of Sprtn-targeted mice. The Sprtn-targeting vector was constructed
in modiﬁed pNTKV1901-frt/loxP22 with a new MfeI site for left homology
arm cloning. Mouse Sprtn genomic sequences were ampliﬁed by PCR from a
BAC clone (RPCI-23 bMQ384-H14) using following primers. Left homology arm
forward, 50-GCATCAGATATCTAAAGGCTTCCTTCCACATGCTAC-30; left
homology arm reverse, 50-GCATCACAATTGATCTCCGAGTTCCAGGCCA
GC-30 ; exon 2 forward, 50-GCATCAAAGCTTGAATTCCCTCCTGCATCTGC
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Figure 6 | Characterization of Sprtn hypomorphic cells and mice. (a) PCR-based genotyping of Sprtnþ /þ , Sprtnþ /H and SprtnH/H mice at weaning.
(b) Quantitative PCR analyses of Sprtn mRNA levels in Sprtnþ /þ and SprtnH/H mice. Sprtn mRNA levels in the kidneys (left) and lungs (right) of two mice
per genotype were measured three times by quantitative reverse transcription PCR and mean±s.d. is shown. Values were normalized to Gapdh and shown
relative to Sprtnþ /þ mouse #27. (c) Growth curves of Sprtnþ /þ , Sprtnþ /H and SprtnH/H mice (n¼ 5, mean±s.d.) of 4–16 weeks. (d,e) Quantitation of
cells containing ﬁve or more gH2AX foci (d) and micronuclei (e) in the indicated Sprtnþ /þ and SprtnH/H primary lung ﬁbroblasts. At least 300 cells were
scored in each experiment and percentages of positive cells are shown. Values are mean±s.d. of three independent experiments. For d,e, statistical
signiﬁcance is Po0.001 (H/H group versus þ /þ group), two-tailed unpaired t-test. (f) Effect of ultraviolet irradiation on replication forks. DNA ﬁber
assays were performed with Sprtnþ /þ and SprtnH/H primary lung ﬁbroblasts with or without ultraviolet irradiation (40 Jm 2) between IdU and CldU
labelling. Distribution of replication forks at different CldU/IdU ratios is shown. A horizontal red line indicates median value.
Table 3 | Karyotypes of primary lung ﬁbroblasts.
Lung ﬁbroblast genotype (n) Mitotic cells inspected % Aneuploid ﬁgures Karyotypes with the indicated chromosome number
37 38 39 40 41 42 43
Sprtnþ /þ (2) 50 12 0 3 1 44 1 1 0
SprtnH/H (2) 50 36 1 5 2 32 6 2 2
Karyotyping was performed with lung ﬁbroblasts isolated from two mice per genotype (#45 and #46 for Sprtnþ /þ , #84 and #87 for SprtnH/H) at passage 5. Twenty-ﬁve mitotic ﬁgures were inspected
for each sample.
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CTTCCACG-30 ; exon 2 reverse, 50-GCATCAGGTACCGTATGGGCTGCTAT
CAAGAACC-30 ; right homology arm forward, 50-GCATCACCGCGG
AAGCTTTGGCTTCAACCACAAGATCCTC-30 ; right homology arm reverse,
50-GCATCAGTCGACTCAGGGACTCCAGATAAGACTAC-30 . After
electroporation into 129Sv/E mouse embryonic stem cells and selection under
G418, correctly targeted clones were injected into blastocysts and resulting
chimeric mice were used to generate SprtnNeo/þ mice. Sprtnþ / mice were
generated by crossing SprtnNeo/þ mice and Cre-transgenic mice. A conditional KO
allele (F allele), in which exon 2 is ﬂoxed, was created by crossing SprtnNeo/þ mice
with FLP-transgenic mice. SprtnF/þ mice were crossed with Cre-ERT2-transgenic
mice (B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J)41 to generate SprtnF/þ ; Cre-ERT2
mice. SprtnH/H mice were generated by intercrossing SprtnNeo/þ mice. All mice
were maintained on a mixed 129Sv/EC57BL/6 genetic background. Genotyping
was performed by PCR analyses of tail DNA using three primers: wild-type-speciﬁc
forward (50-GTGCTGGGATCTGCACCTAT-30), KO-speciﬁc forward (50-
CCATCAGGGACGTTTTCTTG-30) and common reverse (50-TGCACAGCTGT
AAACCCTTG-30). To detect the Neo (H) allele, Neo forward (50-TCCCAAGT
GCTGGGATTAAG-30) and Neo reverse (50-TCGCCTTCTTGACGAGTTCT-30)
primers were used. PCR conditions were 35 cycles of 94 C for 30 s, 60 C for 30 s
and 72 C for 1min. The PCR products are 425 bp (base pair) for the wild-type
allele, 278 bp for the KO allele, 527 bp for the ﬂoxed allele and 442 bp for the Neo
(H) allele. All of the animal procedures were approved by Mayo Clinic Institutional
Animal Care and Use Committee.
In vitro culture of mouse blastocysts. All blastocysts were generated by natural
mating of 2- to 3-month old Sprtnþ / male and Sprtnþ / female mice. The
morning of the day on which a vaginal plug was detected was designated as day
E0.5. Blastocysts were collected on E3.5 by ﬂushing the uteri with M2 medium
(Sigma, #M7167) and cultured on 35-mm glass-bottom dishes (FluoroDish FD35,
World Precision Instruments) in G-1TM v5 PLUS medium (Vitrolife, #10128)
under parafﬁn oil (Vitrolife, #10029). Each blastocyst was photographed daily
using a Zeiss Axio Observer Z1 system with CO2 Module S (5% CO2), Temp-
Module S (37 C), Heating Unit XL S (37 C), A-Pln 10X/0.25 Ph1 objective,
AxioCam MRm camera and AxioVision 4.8 software. Images were exported as jpeg
ﬁles, subsequently cropped and adjusted for brightness and contrast. At day 6, the
blastocyst-outgrowing cells or the undeveloped blastocysts were collected using a
microneedle and suspended in 50 ml lysis buffer (60mM Tris–HCl, pH 9.0, 15mM
[NH4]2SO4, 2mM MgCl2, 0.5% Tween-20 (v/v) and 250 mgml 1 proteinase K)42.
For PCR-based genotyping, 3–10 ml from each sample was used in 25ml reactions.
Genotyping was performed in duplicate and was successful for all of the blastocysts
collected.
Analysis of ageing-associated phenotypes. Body composition was determined
using an EchoMRI-100TM QNMR instrument (Echo Medical Systems, Houston,
Texas) in 12-month-old female mice. Total body fat and lean mass were measured.
Total body fat percentage is equal to fat mass divided by body mass. Bone mineral
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Figure 7 | Premature ageing phenotypes in SprtnH/H mice. (a) Representative images of 12-month-old Sprtnþ /þ and SprtnH/H female mice. Note
lordokyphosis in SprtnH/H indicated by the dotted red line. Scale bar, 1 cm. (b) Representative images of the eyes of Sprtnþ /þ and SprtnH/H female mice.
Note a cataract in SprtnH/H. (c) Body weight, fat mass, body fat percentage and adipose depot weights of 12-month-old Sprtnþ /þ and SprtnH/H female
mice (n¼ 5, mean±s.d.). Values are normalized to the average of the Sprtnþ /þ mice. Because of the smaller body size of the SprtnH/H mice, adipose
depot measurements were ﬁrst calculated relative to body weight. (d) Fat cell diameter measurements (n¼ 5, mean±s.d.). (e) IAT of 12-month-old mice
stained for SA-b-gal activity. (f) Relative expression of senescence markers in 12-month-old IAT (n¼ 5, mean±s.d.). Values were normalized to Gapdh and
are relative to Sprtnþ /þ IAT. (g) Treadmill exercise ability of 12-month-old Sprtnþ /þ and SprtnH/H female mice. Exercise time, distance travelled and
workload performed are shown (n¼ 5, mean±s.d.). For all panels, statistical signiﬁcance is as follows: *Po0.05, **Po0.01, ***Po0.001, ****Po0.0001
(two-tailed unpaired t-test).
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density and bone mineral content were determined with dual-energy X-ray
absorptiometry scanning using a Lunar PIXImus densitometer. Forelimb strength
(N) was determined using a grip strength meter from Columbus Instruments.
Three consecutive days of acclimation occurred before testing. Treadmill exercise
tests were performed as previously described43. Brieﬂy, the mice were put on the
treadmill that was programmed at 5mmin 1 of speed for 2min, which after 2min
was increased to 8mmin 1. The speed of the treadmill was then increased every
2min at the rate of 2mmin 1. The exercise time and distance travelled were
determined at the point when the mice were unable to move along the treadmill.
Work (J) done was determined by: mass (kg) g (9.8m s 2) distance
(m) sin(y) (where, y¼ 5). Individual adipose depots and gastrocnemius muscle
were isolated and weighed on sacriﬁce. All weights were calculated relative to total
body weight. Adipose depot measurements were normalized to the average of the
ﬁve control animals. Formalin-ﬁxed, parafﬁn-embedded inguinal adipose (IAT)
cell and skeletal muscle ﬁbre diameter measurements were performed using a
calibrated computer program (Olympus Microsuite Five)43. Fifty ﬁbres per sample
were measured. To determine SA-b-gal activity, IAT was ﬁxed with ﬁxative
solution containing 2% formaldehyde and 0.2% glutaraldehyde for 12min at room
temperature, followed by 12 h incubation with b-galactosidase staining solution
containing 1mgml 1 X-gal at 37 C.
Plasmids and viral infection. Complementary DNA fragments encoding wild-
type, the E112A mutant, the YFAA mutant (PIP*) and the D473A mutant (UBZ4*)
of human Spartan11,15 were subcloned into a retrovirus vector pMSCV-puro. Wild-
type mouse Spartan and SpartanSHP* (harbouring F254A and L261A mutations)
were cloned into pMSCV-puro with an amino-terminal 3xFlag tag. Full-length Pol
Z cDNA was subcloned from pEGFP-C-pol Z (a gift from Chikahide Masutani and
Fumio Hanaoka) into a lentiviral expression vector pLVX6-IRES-Neo (N-terminal
EGFP tag). Retroviruses and lentiviruses were packaged by cotransfecting viral and
packaging plasmids in a human embryonic kidney cell line 293T (American Type
Culture Collection, CRL-11268). Cells were infected with viral vectors in the
presence of 2 mgml 1 polybrene and selected with 3 mgml 1 puromycin or
400mgml 1 G418.
Cell culture. MEFs were cultured in Dulbecco’s modiﬁed Eagle Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS). Primary SprtnH/ MEFs were
isolated from E13.5 embryos obtained by crossing Sprtnþ / and SprtnH/þ mice.
The H-line MEFs (H2, H3, H5 and H7) were obtained from E13.5 embryos pro-
duced by crossing Sprtnþ / and SprtnF/þ mice and immortalized by serial pas-
sage. For Cre-ERT2 expression in the H-line MEFs, cells were infected with
retroviral vectors and selected with 3 mgml 1 puromycin. The K-line MEFs (K3)
were isolated from E13.5 embryos produced by crossing SprtnF/þ ; Cre-ERT2 and
SprtnF/þ mice and immortalized by retroviral expression of SV40 T-antigen44. To
induce conversion of the ﬂoxed allele to the KO allele in MEFs, cells were treated
with methanol (MeOH) or 2 mM 4-OHT dissolved in MeOH for 2 days. For cell
proliferation assays, 1.5 105 cells were seeded in 10 cm dishes and cell numbers
were recorded every 24 h for 4 days.
Sprtnþ /þ and SprtnH/H primary lung ﬁbroblasts were isolated from lung
tissues of Sprtnþ /þ and SprtnH/H male mice, respectively. Brieﬂy, the lungs were
chopped into small pieces and allowed to sit for few minutes in 100mm dishes.
Culture medium (DMEM supplemented with 10% FBS, non-essential amino acids,
sodium pyruvate and 2-mercaptoethanol) was added to the dishes and cells were
cultured for 4 days. All experiments were performed within three to six passages.
Prostate epithelial cells were isolated as described previously with
modiﬁcations45. Brieﬂy, prostate tissues were chopped into small pieces, minced in
1ml of phosphate-buffered saline (PBS) containing 0.5% BSA and 2mM EDTA
using gentleMACS Dissociator (Miltenyi Biotec) and incubated with 7mgml 1
Liberase blendzyme 3 (Roche) at 37 C for 30min. After subsequent dissociation
with gentleMACS Dissociator and centrifugation (1,000 r.p.m., 15 s), cell
suspensions were collected and cleared from undigested tissues using a cell strainer.
Prostate epithelial cells were then co-cultured with irradiated (3,000 rad) J2
ﬁbroblast feeder cells46 in DMEM/F12 (3:1) supplemented with 10% FBS,
25 ngml 1 hydrocortisone, 0.125 ngml 1 EGF, 5 mgml 1 insulin, 0.1 nM cholera
toxin and 250 ngml 1 Fungizone. Experiments were performed using epithelial
cells at passage 4 after separation from feeder cells.
Flow cytometry. For analyses of DNA content, cells were harvested and ﬁxed with
70% ethanol at  20 C overnight. Fixed cells were stained with propidium iodide
(PI) solution (50mgml 1 PI, 10 mgml 1 RNase A, 0.05% Nonidet P-40 (NP-40))
for at least 30min and analysed by FACS Canto II (BD Biosciences). Percentages of
the cell cycle phases were estimated using ModFit LT (Verity Software House). For
detection of apoptosis, adherent and ﬂoating cells were harvested and stained with
Annexin V-APC (BD Biosciences) for 15min at room temperature. Cells were then
stained with 100 mgml 1 PI and analysed by the ﬂow cytometer.
To analyze S-phase progression, cells were pulse labelled with 10 mM BrdU for
30min and chased in BrdU-free media every 2 h. Cells were harvested and ﬁxed in
70% ethanol at  20 C overnight. DNA was denatured by suspending cells in 2N
HCl with 0.5% Triton X-100 for 30min at room temperature. After neutralization
with 0.1M sodium borate (pH 8.5), cells were labelled with 1 mg of ﬂuorescein
isothiocyanate-conjugated anti-BrdU antibody (Roche, #11202693001) for 30min
at room temperature. Finally, cells were stained with PI solution (50 mgml 1 PI,
10 mgml 1 RNase A, 0.05% NP-40) for at least 30min and analysed by ﬂow
cytometry. For phospho-histone H3 (Ser10), cells were incubated with 40 ngml 1
nocodazole (Sigma) for 4 h, harvested and ﬁxed with 70% ethanol at  20 C
overnight. Cells were washed once with PBS containing 1% BSA (1% BSA/PBS)
and permeabilized with 1% BSA/PBS containing 0.25% Triton X-100 for 5min at
4 C. After washing with 1% BSA/PBS, cells were resuspended in 1 mg of anti-
phospho-H3 (Millipore, #06-570) in 1% BSA/PBS containing 10% normal goat
serum and incubated overnight at 4 C. Cells were washed once with 1% BSA/PBS
and incubated with 7 mg of Alexa Fluor 488-labelled goat anti-rabbit IgG
(Invitrogen, #A11034) in 1% BSA/PBS containing 10% normal goat serum for 1 h
at 4 C. After washing with 1% BSA/PBS, cells were incubated in PI solution for at
least 30min and analysed by ﬂow cytometry.
Cytogenetics. Mitotic cells were enriched by colcemid treatment for 2 h and
harvested by tapping plates. Cells were then swollen in hypotonic buffer for 25min,
ﬁxed and dropped on glass slides. Slides were baked at 90 C for 90min and stained
with Leishman’s stain solution for 1–3min. After a brief rinse with running water,
slides were dried at room temperature and analysed using a bright-ﬁeld micro-
scope. A metaphase spread was considered positive for breakage if any minor
anomalies, major anomalies or radial conﬁgurations were observed.
Chromatin fractionation and western blot. Cells were lysed in NETN lysis buffer
(20mM Tris–HCl, pH 8.0, 100mM NaCl, 0.5% NP-40, 1mM EDTA, 0.5mM NaF,
1mM b-glycerophosphate) supplemented with protease inhibitor mix (Sigma)
followed by sonication. Chromatin-enriched fractionations were isolated by a
previously described method47 with modiﬁcations. Brieﬂy, cells were incubated in
buffer A (10mM Pipes (pH 6.8), 100mM NaCl, 3mM MgCl2, 300mM sucrose,
1mM EGTA, 0.2% Triton X-100, protease inhibitor mix (Sigma)) at 4 C with
rotation for 5min. After centrifugation, pellets were washed again with buffer A
and then incubated on ice for 30min in buffer B (50mM Tris-HCl (pH 7.5),
150mM NaCl, 0.1% SDS) containing 500Uml 1 Benzonase (Merck Millipore)
followed by sonication. Supernatants containing solubilized chromatin proteins
were recovered after centrifugation (14,000 r.p.m., 10min). Thirty micrograms of
proteins was separated by SDS–PAGE, transferred to nitrocellulose membranes
and probed with antibodies. Antibodies against phospho-Chk1 (Ser345) (#2348,
1:1,000) and histone H3 (#9715, 1:5,000) were purchased from Cell Signaling
Technology. Anti-Chk1 (#sc-8408, 1:1,000), anti-PCNA (#sc-56, 1:2,000) and anti-
MCM7 (#sc-9966, 1:1,000) antibodies were from Santa Cruz Biotechnology. Anti-
Chk2 antibodies were obtained from BD Biosciences (#611570, 1:1,000). Anti-Flag
(#F1804, 1:2,000) and anti-b-actin (#A5316, 1:5,000) antibodies were purchased
from Sigma. Mouse anti-human Spartan antibodies were reported previously11.
Immunoﬂuorescence and microscopy. Cells were ﬁxed with 4% paraformalde-
hyde for 10min at room temperature and permeabilized for 10min with 0.2%
Triton X-100. Cells were blocked for 1 h in PBS containing 3% BSA (Rad51), 1%
normal goat serum (53BP1, gH2AX) or 3% normal goat serum (gH2AX for pri-
mary lung ﬁbroblasts) and incubated with primary antibodies diluted in the
respective blocking solution for 1 h at room temperature. Antibodies used were:
rabbit anti-Rad51 (Calbiochem, #PC130, 1:100), rabbit anti-53BP1 (a gift from
Zhenkun Lou, 1:500) and rabbit anti-gH2AX (Cell Signaling Technology, #2577,
1:500). After washing with PBS, cells were stained with secondary antibodies
(Invitrogen, Alexa ﬂuor 488 goat anti-rabbit IgG, #A11034, 1:2,000) diluted in the
blocking solution for 30min at room temperature. Cells were washed with PBS,
stained with DAPI (0.1 mgml 1, Sigma) for 5min and mounted with ProLong
Gold (Invitrogen). For analyses of micronuclei and chromatin bridges, cells were
ﬁxed as above or with methanol:acetone (3:1) for 10min at  20 C and per-
meabilized for 10min with 0.2% Triton X-100 at room temperature, stained with
DAPI (0.1 mgml 1, Sigma) for 5min and mounted with ProLong Gold (Invitro-
gen). Slides were viewed and photographed on a Zeiss ﬂuorescent microscope with
a  100 objective.
DNA ﬁber assays. Cells were labelled with 25 mM IdU (Sigma) for 15min, washed
twice with pre-warmed PBS and labelled with 200mM CldU (Sigma) for 15min. To
measure fork progression at DNA lesions, cells were irradiated with 40 Jm 2
ultraviolet in 5ml media containing 1% FBS in 100mm dish between IdU and
CldU labelling. Labelled cells were harvested and mixed with unlabelled cells at
1:40 and concentrations were adjusted to 3–5 105ml 1 in PBS. Five microlitres
of cell suspension was dropped on a glass slide and cells were lysed by adding 15 ml
spreading buffer (200mM Tris–HCl, pH 7.4, 50mM EDTA, 0.5% SDS). After
8min incubation at room temperature, DNA was spread by tilting glass slides and
ﬁxed with methanol/acetic acid (3:1) for 10min. Slides were incubated with 2.5M
HCl for 1 h, neutralized by rinsing twice with 0.1M sodium borate (pH 8.5),
washed with PBS, blocked with PBS containing 5% goat serum for 1 h and incu-
bated with anti-IdU antibodies (BD Biosciences, #347580, 1:100 in PBS containing
5% goat serum) overnight at 4 C. After washing with low-salt TBST (36mM
Tris–HCl, pH 8.0, 50mM NaCl, 0.5% Tween-20) for 20min and then twice with
PBST (PBS containing 0.2% Tween-20), slides were incubated with anti-CldU
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antibodies (Abcam, #ab6326, 1:1,000 in PBS containing 5% goat serum) overnight
at 4 C. Slides were washed three times with PBST and incubated with secondary
antibodies (Invitrogen, Alexa ﬂuor 594 anti-mouse IgG, #A11032, Alexa ﬂuor 488
anti-rat IgG, #A11006, 1:2,000 in PBS containing 5% goat serum) for 30min at
37 C. After washing with PBST, slides were mounted with ProLong Gold (Invi-
trogen). Slides were viewed and photographed on a Zeiss ﬂuorescent microscope
with a  100 objective. The lengths of IdU and CldU tracts were measured using
the ImageJ software.
Quantitative reverse transcription-PCR. Total RNA was isolated from the
kidneys and lungs of Sprtnþ /þ and SprtnH/H mice using TRIzol (Invitrogen) and
from MEFs and IAT using RNeasy Kit (Qiagen). cDNAs were generated using
oligo(dT) primers and SuperScript III (Invitrogen). Quantitative PCR was per-
formed in triplicate for each sample on CFX96 (Bio-Rad) using iTaq Universal
SYBR Green Supermix (Bio-Rad) or on ABI PRISM 7900 Sequence Detection
System (Applied Biosystems) using SYBR green PCR Master Mix (Applied
Biosystems). To quantify the wild-type Sprtn transcripts, primers were designed
at the junction of exon 2 and exon 3 (forward primer: 50-GGACCTTGTAG
AGACTCTTTTG-30) and in exon 4 (reverse primer: 50-CCTCATCATGGA
AAGTGTGG-30) (Supplementary Fig. 4a). Gapdh was ampliﬁed using forward
primer (50-AGAACATCATCCCTGCATCC-30) and reverse primer (50-CACAT
TGGGGGTAGGAACAC-30) and used for normalization between samples. For
senescence-associated markers, following primers were used: p16Ink4a forward,
50-CCCAACGCCCCGAACT-30 ; p16Ink4a reverse, 50-GCAGAAGAGCTGCTA
CGTGAA-30 ; p19ARF forward, 50-AACTCTTTCGGTCGTACCCC-30 ; p19ARF
reverse, 50-GCGTGCTTGAGCTGAAGCTA-30; Pai1 forward, 50-TCAGAGCA
ACAAGTTCAACTACACTGAG-30 ; Pai1 reverse 50-CCCACTGTCAAGGCTCC
ATCACTTGCCCCA-30 ; Il6 forward, 50-GACAACTTTGGCATTGTGG-30; Il6
reverse, 50-ATGCAGGGATGATGTTCTG-30; Gapdh forward, 50-ACCACAGTC
CATGCCATCAC-30 ; Gapdh reverse, 50-TCCACCACCCTGTTGCTGTA-30 .
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